Skip to main content
. 2019 Aug 2;12:2397–2407. doi: 10.2147/IDR.S217044

Table 2.

Drug-resistant profile among TB-DM patients and TB-No DM patients

Drug resistance DR-TB patients without diabetes n=1153/6797 (16.96%) DR-TB patients with diabetes n=93/426 (21.83%) P-value
DR-TB (total) 1153 (16.96) 93 (21.83) 0.01*
Any resistance to first-line drug
INH 659 (9.70) 52 (12.21) 0.09
RFP 298 (4.38) 25 (5.87) 0.15
EMB 91 (1.34) 7 (1.64) 0.60
SM 795 (11.70) 69 (16.20) 0.005**
MR TB (total) 678 (9.97) 50 (11.74) 0.24
INH 216 (3.18) 13 (3.05) 0.89
RFP 58 (0.85) 4 (0.94) 0.78
EMB 13 (0.19) 0 (0.00) 1.00
SM 386 (5.68) 33 (7.75) 0.08
Others 5 (0.07) 0 (0.00) 1.00
MDR (total) 213 (3.13) 17 (4.00) 0.33
MDR1:INH+RFP 46 (0.68 6 (1.41) 0.08
MDR2:INH+RFP+EMB+SM 45 (0.66) 6 (1.41) 0.07
MDR3:INH+RFP+SM 110 (1.62) 5 (1.17) 0.48
Others 12 (0.18) 0 (0.00) 1.00
PDR 258 (3.80) 26 (6.10) 0.02*
PDR1:INH+EMB 7 (0.10) 1 (0.23) 0.39
PDR2:INH+SM 213 (3.13) 21 (4.93) 0.04*
PDR3:RFP+SM 20 (0.29) 4 (0.94) 0.05
Others 18 (0.26) 0 (0.00) 0.62

Note: *P<0.05; **P<0.01.

Abbreviations: TB, tuberculosis; DR-TB, drug-resistant tuberculosis; MR-TB, monoresistant tuberculosis; MDR-TB, multiresistant tuberculosis; PDR-TB, polydrug resistant tuberculosis; EMB, ethambutol; INH, isoniazid; RFP, rifampin; SM, streptomycin.